Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 30490, 9 pages
http://dx.doi.org/10.1155/MI/2006/30490
Research Communication

Theaflavin Ameliorates Cerebral Ischemia-Reperfusion Injury in Rats Through Its Anti-Inflammatory Effect and Modulation of STAT-1

1Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China
2Department of Pharmacology, Medical College, Xianning University, 3 Guihua Road, Xianning 437100, China
3Department of Pharmacology, Medical College, Wuhan University, 39 Donghu Road, Wuhan 430071, China

Received 30 March 2006; Revised 30 August 2006; Accepted 30 August 2006

Copyright © 2006 Fei Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C JM Klijn and G J Hankey, “Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative,” Lancet Neurology, vol. 2, no. 11, pp. 698–701, 2003. View at Publisher · View at Google Scholar
  2. E H Lo, T Dalkara, and M A Moskowitz, “Mechanisms, challenges and opportunities in stroke,” Nature Reviews Neuroscience, vol. 4, no. 5, pp. 399–415, 2003. View at Publisher · View at Google Scholar
  3. A Nurmi, P J Lindsberg, M Koistinaho et al., “Nuclear factor-?B contributes to infarction after permanent focal ischemia,” Stroke, vol. 35, no. 4, pp. 987–991, 2004. View at Publisher · View at Google Scholar
  4. P M Kochanek and J M Hallenbeck, “Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke,” Stroke, vol. 23, no. 9, pp. 1367–1379, 1992. View at Google Scholar
  5. L A Heinel, S Rubin, R H Rosenwasser, U S Vasthare, and R F Tuma, “Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion,” Brain Research Bulletin, vol. 34, no. 2, pp. 137–141, 1994. View at Publisher · View at Google Scholar
  6. J M Kuldo, J Westra, S A Àsgeirsdóttir et al., “Differential effects of NF-?B and p38 MAPK inhibitors and combinations thereof on TNF-a- and IL-1ß-induced proinflammatory status of endothelial cells in vitro,” American Journal of Physiology - Cell Physiology, vol. 289, no. 5, pp. C1229–C1239, 2005. View at Publisher · View at Google Scholar
  7. Y Sugama, C Tiruppathi, K Offakidevi, T T Andersen, J W II Fenton, and A B Malik, “Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion,” Journal of Cell Biology, vol. 119, no. 4, pp. 935–944, 1992. View at Publisher · View at Google Scholar
  8. O Hayaishi, “Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2,” FASEB Journal, vol. 5, no. 11, pp. 2575–2581, 1991. View at Google Scholar
  9. W E Kaufmann, K I Andreasson, P C Isakson, and P F Worley, “Cyclooxygenases and the central nervous system,” Prostaglandins, vol. 54, no. 3, pp. 601–624, 1997. View at Publisher · View at Google Scholar
  10. Y Matsuoka, M Okazaki, H Zhao, S Asai, K Ishikawa, and Y Kitamura, “Phosphorylation of c-Jun and its localization with heme oxygenase-1 and cyclooxygenase-2 in CA1 pyramidal neurons after transient forebrain ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 11, pp. 1247–1255, 1999. View at Google Scholar
  11. C Iadecola, C Forster, S Nogawa, H B Clark, and M E Ross, “Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia,” Acta Neuropathologica, vol. 98, no. 1, pp. 9–14, 1999. View at Publisher · View at Google Scholar
  12. S Miettinen, F R Fusco, J Yrjänheikki et al., “Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6500–6505, 1997. View at Publisher · View at Google Scholar
  13. S Nogawa, F Zhang, M E Ross, and C Iadecola, “Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage,” Journal of Neuroscience, vol. 17, no. 8, pp. 2746–2755, 1997. View at Google Scholar
  14. M Nakayama, K Uchimura, R L Zhu et al., “Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10954–10959, 1998. View at Publisher · View at Google Scholar
  15. S Govoni, E Masoero, L Favalli et al., “The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat,” Neuroscience Letters, vol. 303, no. 2, pp. 91–94, 2001. View at Publisher · View at Google Scholar
  16. S Doré, T Otsuka, T Mito et al., “Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction,” Annals of Neurology, vol. 54, no. 2, pp. 155–162, 2003. View at Publisher · View at Google Scholar
  17. S Nogawa, C Forster, F Zhang, M Nagayama, M E Ross, and C Iadecola, “Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10966–10971, 1998. View at Publisher · View at Google Scholar
  18. A F Samdani, T M Dawson, and V L Dawson, “Nitric oxide synthase in models of focal ischemia,” Stroke, vol. 28, no. 6, pp. 1283–1288, 1997. View at Google Scholar
  19. C Iadecola, “Bright and dark sides of nitric oxide in ischemic brain injury,” Trends in Neurosciences, vol. 20, no. 3, pp. 132–139, 1997. View at Publisher · View at Google Scholar
  20. T Goyagi, S Goto, A Bhardwaj, V L Dawson, P D Hurn, and J R Kirsch, “Neuroprotective effect of σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production,” Stroke, vol. 32, no. 7, pp. 1613–1620, 2001. View at Google Scholar
  21. C Iadecola, F Zhang, R Casey, M Nagayama, and M E Ross, “Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene,” Journal of Neuroscience, vol. 17, no. 23, pp. 9157–9164, 1997. View at Google Scholar
  22. R Bolli, S Manchikalapudi, X-L Tang et al., “The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning,” Circulation Research, vol. 81, no. 6, pp. 1094–1107, 1997. View at Google Scholar
  23. Y Guo, W K Jones, Y-T Xuan et al., “The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11507–11512, 1999. View at Publisher · View at Google Scholar
  24. K Shinmura, X-L Tang, Y Wang et al., “Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 18, pp. 10197–10202, 2000. View at Publisher · View at Google Scholar
  25. Y Takagi, J Harada, A Chiarugi, and M A Moskowitz, “STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 11, pp. 1311–1318, 2002. View at Google Scholar
  26. D A West, L M Valentim, M F Lythgoe et al., “MR image-guided investigation of regional signal transducers and activators of transcription-1 activation in a rat model of focal cerebral ischemia,” Neuroscience, vol. 127, no. 2, pp. 333–339, 2004. View at Publisher · View at Google Scholar
  27. L K Leung, Y Su, R Chen, Y Huang, and Z-Y Chen, “Theaflavins in black tea and catechins in green tea are equally effective antioxidants,” Journal of Nutrition, vol. 131, no. 9, pp. 2248–2251, 2001. View at Google Scholar
  28. J D Lambert and C S Yang, “Mechanisms of cancer prevention by tea constituents,” Journal of Nutrition, vol. 133, no. 10, pp. 3262S–3267S, 2003. View at Google Scholar
  29. J V Higdon and B Frei, “Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions,” Critical Reviews in Food Science and Nutrition, vol. 43, no. 1, pp. 89–143, 2003. View at Publisher · View at Google Scholar
  30. C S Yang and J M Landau, “Effects of tea consumption nutrition health,” Journal of Nutrition, vol. 130, no. 10, pp. 2409–2412, 2000. View at Google Scholar
  31. H Mukhtar and N Ahmad, “Tea polyphenols: prevention of cancer and optimizing health,” American Journal of Clinical Nutrition, vol. 71, no. suppl 6, pp. 1698S–1704S, 2000. View at Google Scholar
  32. Y B Choi, Y I Kim, K S Lee, B S Kim, and D J Kim, “Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats,” Brain Research, vol. 1019, no. 1-2, pp. 47–54, 2004. View at Publisher · View at Google Scholar
  33. M Menegazzi, E Tedeschi, D Dussin et al., “Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation,” FASEB journal, vol. 15, no. 7, pp. 1309–1311, 2001. View at Google Scholar
  34. E Z Longa, P R Weinstein, S Carlson, and R Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Google Scholar
  35. Y Matsuo, H Onodera, Y Shiga et al., “Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion,” Stroke, vol. 25, no. 7, pp. 1469–1475, 1994. View at Google Scholar
  36. S-J Liu, S-W Zhou, and C-S Xue, “Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion,” Acta Pharmacologica Sinica, vol. 22, no. 11, pp. 971–975, 2001. View at Google Scholar
  37. S Jander, M Schroeter, and G Stoll, “Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia,” Journal of Neuroimmunology, vol. 109, no. 2, pp. 181–187, 2000. View at Publisher · View at Google Scholar
  38. J R Vane, Y S Bakhle, and R M Botting, “Cyclooxygenases 1 and 2,” Annual Review of Pharmacology and Toxicology, vol. 38, no. 1, pp. 97–120, 1998. View at Publisher · View at Google Scholar
  39. E Candelario-Jalil, A González-Falcón, M García-Cabrera et al., “Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia,” Journal of Neurochemistry, vol. 86, no. 3, pp. 545–555, 2003. View at Publisher · View at Google Scholar
  40. T Ohtsuki, K Kitagawa, K Yamagata et al., “Induction of cyclooxygenase-2 mRNA in gerbil hippocampal neurons after transient forebrain ischemia,” Brain Research, vol. 736, no. 1-2, pp. 353–356, 1996. View at Publisher · View at Google Scholar
  41. S J Hewett, T F Uliasz, A S Vidwans, and J A Hewett, “Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture,” Journal of Pharmacology and Experimental Therapeutics, vol. 293, no. 2, pp. 417–425, 2000. View at Google Scholar
  42. M Kittaka, S L Giannotta, V Zelman et al., “Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model,” Journal of Neurosurgery, vol. 87, no. 5, pp. 731–737, 1997. View at Google Scholar
  43. U Dirnagl, C Iadecola, and M A Moskowitz, “Neurobiology of ischemic stroke: an integrated view,” Trends in Neurosciences, vol. 22, no. 9, pp. 391–397, 1989. View at Publisher · View at Google Scholar
  44. M H Jiang, T Kaku, J Hada, and Y Hayashi, “7-Nitroindazole reduces nitric oxide concentration in rat hippocampus after transient forebrain ischemia,” European Journal of Pharmacology, vol. 380, no. 2-3, pp. 117–121, 1999. View at Publisher · View at Google Scholar
  45. K Nanri, C Montécot, V Springhetti, J Seylaz, and E Pinard, “The selective inhibitor of neuronal nitric oxide synthase, 7- nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats,” Stroke, vol. 29, no. 6, pp. 1248–1254, 1998. View at Google Scholar
  46. M Endoh, K Maiese, and J Wagner, “Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia,” Brain Research, vol. 651, no. 1-2, pp. 92–100, 1994. View at Publisher · View at Google Scholar
  47. U Dirnagl, C Iadecola, and M A Moskowitz, “Pathobiology of ischaemic stroke: an integrated view,” Trends in Neurosciences, vol. 22, no. 9, pp. 391–397, 1999. View at Publisher · View at Google Scholar
  48. P C Heinrich, I Behrmann, G Müller-Newen, F Schaper, and L Graeve, “Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway,” Biochemical Journal, vol. 334, no. pt 2, pp. 297–314, 1998. View at Google Scholar
  49. E Cattaneo, L Conti, and C De-Fraja, “Signalling through the JAK-STAT pathway in the developing brain,” Trends in Neurosciences, vol. 22, no. 8, pp. 365–369, 1999. View at Publisher · View at Google Scholar
  50. Y Shen, K Schlessinger, X Zhu et al., “Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation,” Molecular and Cellular Biology, vol. 24, no. 1, pp. 407–419, 2004. View at Publisher · View at Google Scholar
  51. R Kamijo, H Harada, T Matsuyama et al., “Requirement for transcription factor IRF-1 in NO synthase induction in macrophages,” Science, vol. 263, no. 5153, pp. 1612–1615, 1994. View at Publisher · View at Google Scholar
  52. Y-T Xuan, Y Guo, Y Zhu et al., “Mechanism of cyclooxygenase-2 upregulation in late preconditioning,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 5, pp. 525–537, 2003. View at Publisher · View at Google Scholar